NWQ Investment Management Company’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$21.5M Sell
187,481
-14,254
-7% -$1.68M 0.97% 42
2020
Q2
$23K Sell
201,735
-25,022
-11% -$2.65M 0.77% 33
2020
Q1
$18.2M Buy
226,757
+74,293
+49% +$7.69M 0.73% 50
2019
Q4
$16.3M Sell
152,464
-4,432
-3% -$462K 0.41% 91
2019
Q3
$16.8M Sell
156,896
-5,190
-3% -$533K 0.41% 92
2019
Q2
$16.5M Sell
162,086
-6,100
-4% -$586K 0.37% 96
2019
Q1
$15.1M Buy
+168,186
New +$14.6M 0.33% 105

Other funds holding DGX

NWQ Investment Management Company's DGX Position: Q3 2020 in Review

NWQ Investment Management Company reduced its Quest Diagnostics (DGX) stake by 7.1% in Q3 2020, selling an estimated $1.68M and leaving 187,481 shares worth $21.5M. The position accounts for 0.97% of the portfolio, ranked #42.

NWQ Investment Management Company first reported a position in DGX in Q1 2019 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold DGX as of Q3 2020.

  • NWQ Investment Management Company held 187,481 shares of Quest Diagnostics worth $21.5M as of Q3 2020.
  • NWQ Investment Management Company sold 14,254 Quest Diagnostics shares in Q3 2020, an estimated $1.68M.
  • Quest Diagnostics made up 0.97% of NWQ Investment Management Company's portfolio in Q3 2020, its #42 holding.
  • NWQ Investment Management Company first reported a position in Quest Diagnostics in Q1 2019 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2020.

Based on NWQ Investment Management Company's 13F filing for Q3 2020, filed 16 Nov 2020.